comparemela.com

Page 13 - Rapid Test Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roundup: DNA Script signs contract with French Department of Defence, Octopus Ventures announces new health tech team and more briefs

RACCOON.WORLD RAISES FUNDING FOR PHYSIOTHERAPY TELEMEDICINE EU-based digital physiotherapy startup, Raccoon.World has raised €660K in funding from Fast Track to Innovation (FTI). The money will be spent on further R&D, scientific research and certification of the renewed product, as well as potential partners. The startups platform, Raccoon.Recovery allows physiotherapy professionals to build a treatment course digitally with patients who have musculoskeletal disorders or are recovering from a stroke. The platform focuses on examination of patient condition to building a gamified exercise course and patient progress monitoring. The funding will also go to further product development, including scaling to full-body product from hand-and-arm solution, clinical trials of new solution functionality that will expand the automation of therapists’ everyday routine, IP protection and an MDR certification of the renewed product as a medical device. The grant programme will last app

Panbio™ COVID-19 Ag Rapid Test Device receives CE mark

Product News: Abbott s Panbio rapid antigen test receives CE mark 26 Jan 2021 Abbott has announced that it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus. Panbio COVID-19 Ag s label has been updated with clinical data on asymptomatic individuals, which enables mass testing (mass screening) of people who do not currently present symptoms of the disease. According to a recent study published in the Journal of the American Medical Association, at least 50% of COVID-19 infections are estimated to have originated from exposure to asymptomatic individuals. The other update to the label allows self-collection of nasal specimens under the supervision of a healthcare worker. Self-swabbing with a patient-friendly nasal swab improves patient comfort and reduces the risk of accidental exposure to the virus for healthcare workers as they can maintain distance during the testing procedure.

Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device

Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device NORTH CHICAGO (dpa-AFX) - Abbott (ABT) said it has received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing. Panbio COVID-19 Ag s label has been updated with clinical data on asymptomatic individuals, which enables mass testing (mass screening) of people who do not currently present symptoms of the disease. Panbio Rapid Antigen Test is approved for use with a patient-friendly and minimally invasive nasal swab. Patients can self-administer sample collection under a healthcare professional s supervision, the company said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.